Read Publication
http://dx.doi.org/10.1177/1078155217712402
The following have contributed to this page: Reyad Dada
This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Why overall survival and not progression free survival improves in era of program death inhibitors
- Reyad Dada
- Journal of Oncology Pharmacy Practice, May 2017, SAGE Publications
- DOI: 10.1177/1078155217712402
